Market Overview:
The global respiratory drug delivery devices market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of respiratory diseases, growing geriatric population, and technological advancements in respiratory drug delivery devices. The global respiratory drug delivery devices market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into metered dose inhalers (MDI), dry powder inhalers (DPI), and nebulizers. MDIs are further sub-segmented into pressurized metered dose inhalers (pMDIs) and breath-actuated metered dose inhalers (bMDIs). DPI is further sub-segmented into single-dose dry powder inhalers (SDDPIs) and multiple-dose dry powder inhalers (MDDPIs). Nebulizers are further sub-segmented into ultrasonic nebulizers and mesh nebulizers. On the basis of application, the market is segmented into asthma, COPD, cystic fibrosis, bronchiectasis,, pulmonary embolism,, idiopathic pulmonary fibrosis,, sarcoidosis,, pneumothorax,, lung cancer,.and others (). Asthma accounts for majority share in terms of applications followed by COPD and cystic fibrosis respectively.
Product Definition:
A respiratory drug delivery device is a tool used to administer medication directly to the lungs. This type of device can be used to treat a variety of conditions, including asthma, emphysema, and cystic fibrosis. The importance of respiratory drug delivery devices lies in their ability to provide medication directly to the lungs, where it can be most effective.
Metered Dose Inhalers (MDI):
MDI is a respiratory drug delivery device that delivers medication by metered dose inhalation through the mouth and nose. MDI devices are portable, easy to use, and have fewer adverse effects than other forms of respiratory medication such as nebulizers or dry powder inhalers.
The global Metered Dose Inhaler (MDI) market was valued at USD 1.6 billion in 2015.
Dry Powder Inhalers (DPI):
Dry powder inhalers (DPIs) are a type of respiratory drug delivery device. They consist of a capsule or cartridge containing the medication to be inhaled and are activated by the pressing of a button. DPI’s work by expanding air into a fine mist, which carries the medicine inside the lungs where it is lungs most effective and efficient to deliver it.
Application Insights:
Asthma held the largest share of 42.0% in 2017 owing to the increasing prevalence of asthma and growing awareness about its management. According to estimates by Global Asthma Report Card, in 2016, around 300 million people were affected by asthma worldwide, which was a rise of approximately 70 million compared with 10 years ago.
The number of deaths caused by asthma has been rising steadily over the past few years and stood at around 33000 per year globally according to estimates published in The Lancet Planetary Health Series (2017). Increasing incidence rate coupled with high mortality rate is expected to drive demand for ADDs over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, favorable reimbursement policies, and rising awareness about respiratory diseases are some of the factors responsible for its dominance. Moreover, increasing government initiatives to promote the use of these devices is also expected to drive growth during the forecast period.
Asia Pacific is expected to be one of fastest growing regions over the forecast period owing to high unmet clinical needs coupled with rapidly improving healthcare infrastructure especially in India & China as well as other emerging economies such as Singapore and Malaysia.
Growth Factors:
- Increasing incidence of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and pneumonia is expected to drive the demand for respiratory drug delivery devices over the forecast period.
- Growing geriatric population is also anticipated to boost the market growth owing to higher prevalence of respiratory diseases in this population.
- Technological advancements in respiratory drug delivery devices are expected to provide new opportunities for market growth over the next few years.
- Rising awareness about benefits of using these devices is projected to propel demand for respiratory drug delivery devices during the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Respiratory Drug Delivery Devices Market Research Report
By Type
Metered Dose Inhalers (MDI), Dry Powder Inhalers (DPI), Nebulizers
By Application
Asthma, COPD, Cystic Fibrosis
By Companies
Philips Healthcare, Bespak, Omron Corporation, ...
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global Respiratory Drug Delivery Devices Market Report Segments:
The global Respiratory Drug Delivery Devices market is segmented on the basis of:
Types
Metered Dose Inhalers (MDI), Dry Powder Inhalers (DPI), Nebulizers
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Asthma, COPD, Cystic Fibrosis
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Philips Healthcare
- Bespak
- Omron Corporation
- ...
Highlights of The Respiratory Drug Delivery Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Metered Dose Inhalers (MDI)
- Dry Powder Inhalers (DPI)
- Nebulizers
- By Application:
- Asthma
- COPD
- Cystic Fibrosis
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Respiratory Drug Delivery Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Respiratory drug delivery devices are medical devices that help deliver medications to the lungs. They can be used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and pneumonia.
Some of the key players operating in the respiratory drug delivery devices market are Philips Healthcare, Bespak, Omron Corporation.
The respiratory drug delivery devices market is expected to register a CAGR of 6.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Respiratory Drug Delivery Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Respiratory Drug Delivery Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Respiratory Drug Delivery Devices Market - Supply Chain
4.5. Global Respiratory Drug Delivery Devices Market Forecast
4.5.1. Respiratory Drug Delivery Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Respiratory Drug Delivery Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Respiratory Drug Delivery Devices Market Absolute $ Opportunity
5. Global Respiratory Drug Delivery Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Respiratory Drug Delivery Devices Market Size and Volume Forecast by Type
5.3.1. Metered Dose Inhalers (MDI)
5.3.2. Dry Powder Inhalers (DPI)
5.3.3. Nebulizers
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Respiratory Drug Delivery Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Respiratory Drug Delivery Devices Market Size and Volume Forecast by Application
6.3.1. Asthma
6.3.2. COPD
6.3.3. Cystic Fibrosis
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Respiratory Drug Delivery Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Respiratory Drug Delivery Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Respiratory Drug Delivery Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Respiratory Drug Delivery Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Respiratory Drug Delivery Devices Demand Share Forecast, 2019-2029
9. North America Respiratory Drug Delivery Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Respiratory Drug Delivery Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Respiratory Drug Delivery Devices Market Size and Volume Forecast by Application
9.4.1. Asthma
9.4.2. COPD
9.4.3. Cystic Fibrosis
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Respiratory Drug Delivery Devices Market Size and Volume Forecast by Type
9.7.1. Metered Dose Inhalers (MDI)
9.7.2. Dry Powder Inhalers (DPI)
9.7.3. Nebulizers
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Respiratory Drug Delivery Devices Demand Share Forecast, 2019-2029
10. Latin America Respiratory Drug Delivery Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Respiratory Drug Delivery Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Respiratory Drug Delivery Devices Market Size and Volume Forecast by Application
10.4.1. Asthma
10.4.2. COPD
10.4.3. Cystic Fibrosis
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Respiratory Drug Delivery Devices Market Size and Volume Forecast by Type
10.7.1. Metered Dose Inhalers (MDI)
10.7.2. Dry Powder Inhalers (DPI)
10.7.3. Nebulizers
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Respiratory Drug Delivery Devices Demand Share Forecast, 2019-2029
11. Europe Respiratory Drug Delivery Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Respiratory Drug Delivery Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Respiratory Drug Delivery Devices Market Size and Volume Forecast by Application
11.4.1. Asthma
11.4.2. COPD
11.4.3. Cystic Fibrosis
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Respiratory Drug Delivery Devices Market Size and Volume Forecast by Type
11.7.1. Metered Dose Inhalers (MDI)
11.7.2. Dry Powder Inhalers (DPI)
11.7.3. Nebulizers
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Respiratory Drug Delivery Devices Demand Share, 2019-2029
12. Asia Pacific Respiratory Drug Delivery Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Respiratory Drug Delivery Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Respiratory Drug Delivery Devices Market Size and Volume Forecast by Application
12.4.1. Asthma
12.4.2. COPD
12.4.3. Cystic Fibrosis
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Respiratory Drug Delivery Devices Market Size and Volume Forecast by Type
12.7.1. Metered Dose Inhalers (MDI)
12.7.2. Dry Powder Inhalers (DPI)
12.7.3. Nebulizers
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Respiratory Drug Delivery Devices Demand Share, 2019-2029
13. Middle East & Africa Respiratory Drug Delivery Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Respiratory Drug Delivery Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Respiratory Drug Delivery Devices Market Size and Volume Forecast by Application
13.4.1. Asthma
13.4.2. COPD
13.4.3. Cystic Fibrosis
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Respiratory Drug Delivery Devices Market Size and Volume Forecast by Type
13.7.1. Metered Dose Inhalers (MDI)
13.7.2. Dry Powder Inhalers (DPI)
13.7.3. Nebulizers
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Respiratory Drug Delivery Devices Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Respiratory Drug Delivery Devices Market: Market Share Analysis
14.2. Respiratory Drug Delivery Devices Distributors and Customers
14.3. Respiratory Drug Delivery Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Philips Healthcare
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Bespak
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Omron Corporation
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. ...
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. COMPANY5
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
